Skip to content

Safety and Efficacy of Local Anesthesia in Emergency Inguinal Hernia Surgery

Safety and Efficacy of Local Anesthesia in Emergency Inguinal Hernia Surgery, a Prospective Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02599623
Enrollment
80
Registered
2015-11-06
Start date
2016-01-31
Completion date
2019-12-31
Last updated
2016-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Incarcerated Inguinal Hernia

Keywords

Incarcerated, Anesthesia, Hernia

Brief summary

This prospective randomized is designed to evaluate the safety and efficacy of hernia repairs using local anesthesia compared with those using general anesthesia for patients with incarcerated hernia.

Detailed description

The outcome parameters measured included intraoperative conditions, postoperative conditions and long-term follow-up conditions.

Interventions

PROCEDURELocal Anesthesia

Patients in LA group received the local infiltration technique. A mixture of 2% lidocaine 20ml and 0.9%NS 30ml was used as the local anesthetic. Patients required extra analgesia during the surgery were given 20-40mg parecoxib sodium intravenously. Conversion to GA was performed if LA was intolerant for patient, which was evaluated by both anesthetists and surgeons.

PROCEDUREGeneral Anesthesia

In group GA, anesthesia was induced with propofol 2mg/kg and fentanyl 0.1-0.2mg intravenously. Inhalation anesthesia was given at the same time with a mixture of oxygen and isoflurane 1-2% through an intubation.

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-70 years 2. Primary inguinal hernia 3. ASA I-II 4. Clinical diagnosis of incarcerated hernia 5. randomly select patch agreed by patients and family members

Exclusion criteria

1. severe organ dysfunction 2. No-tolerate anesthesia 3. No-suitable for operation 4. spirit disease patients 5. automatically exit

Design outcomes

Primary

MeasureTime frame
Recurrence rate1 year

Secondary

MeasureTime frame
Time to eat1 week to 1 month
Time to ambulation1 week to 1 month
Total cost1 week to 1 month
Time in ICU1 week
Time in hospital1 week to 1 month
Death in 30 days rate1 month
Complication rates1 week to 1 month

Countries

China

Contacts

Primary ContactTAO CHEN, M.D.
dr_chentao78@163.com+8613601779874

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026